Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Chronic hepatitis B
Age: Adult
Dose: Oral – 600 mg
Frequency: once daily

Child Dose

Clinical InformationAdministration Information
Age: Child greater than 16 years
Dose: Oral – 600 mg
Frequency: once daily
Note: Safety and efficacy not established.

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment: End-Stage Renal Disease
Dose: 600 mg
Frequency: every 96 hours
Note: after dialysis session
Condition: Renal impairment: Creatinine Clearance less than 30 milliliters per minute (not requiring dialysis)
Dose: 600 mg
Frequency: every 72 hours
Administration
  • Can be taken with or without food
  • Take at same time each day
Side Effect

Drug Interaction

Drug NameRisk Factors
Peginterferon alfa-2a
Increased risk of peripheral neuropathy

Disease Interaction

Disease NameRisk Factors
Concurrent Peginterferon Alfa-2A Use
Risk of peripheral neuropathy

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store Telbivudine Tablets and Oral Solution in the original bottle at room temperature (15° to 30°C)

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.